Cleared Traditional

K833142 - ANTIBODY TO INTRINSIC FACTOR RADIOASSAY

K833142 is an FDA 510(k) clearance for ANTIBODY TO INTRINSIC FACTOR RADIOASSAY, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 Chemistry device with product code CDD cleared through the Traditional 510(k) pathway after a 138-day FDA review.

K833142 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
138d
Days
Class 2
Risk

K833142 is an FDA 510(k) clearance for the ANTIBODY TO INTRINSIC FACTOR RADIOASSAY. Classified as Radioassay, Vitamin B12 (product code CDD), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Washington, US). The FDA issued a Cleared decision on January 30, 1984 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1810 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K833142

510(k) Number K833142 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 1983
Decision Date January 30, 1984
Days to Decision 138 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 88d · This submission: 138d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDD Device Classification - Class 2, Special Controls

Product Code CDD Radioassay, Vitamin B12
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDD Radioassay, Vitamin B12

All 67
Devices cleared under the same product code (CDD) and FDA review panel - the closest regulatory comparables to K833142.
MAGIC NO BOIL B12/FOLATE RADIOIMMUNOASSAY
K854945 · Ciba Corning Diagnostics Corp. · Feb 1986
MICROMEDIC COMBOSTAT B B12/FOLATE(BOIL)
K853127 · Micromedic Systems · Sep 1985
VITAMIN B12 57CO/FOLATE 125I -
K840462 · Corning Medical & Scientific · Jun 1984
QUANTAPHASE B-12-COBALMIN-FOLATE-
K833247 · Bio-Rad · Oct 1983
VITAMIN B12 RADIOASSAY KIT CA-1534
K832710 · Clinical Assays, Inc. · Oct 1983
VITAMIN B12 FOLATE CA-1515-125
K832711 · Clinical Assays, Inc. · Oct 1983